2289.HKSE: Charmacy Pharmaceutical Corporation
Below is just a sample of the Company website (source: About Us / CH’MEI Overview ) Story Floods has reviewed with some preliminary suggestions. Should the Company decides to accept these edits, please extend the professional curtesy of informing Story Floods at support@storyfloods.com ; or if the Company has further questions, please also feel free to contact Story Floods at support@storyfloods.com
| Items | Suggest the Following Edits (as of Feb 10, 2021) |
|---|---|
| 1 | change to “Charmacy Pharmaceutical Co., Ltd. (“Charmacy Pharmaceutical”, or “the Company”; stock code: 2289.HKSE), was founded in 2011 as Guangdong Charmacy Pharmaceutical Co., Ltd., in the eastern region of Guangdong Province, China. The Company’s business operation is all around the Pearl River Delta. In the first half of 2017, the Company acquired Zhuhai Chuangmei Hengxiang Pharmaceutical Co., Ltd. and Guangzhou Charmacy Pharmaceutical Co., Ltd.” |
| 2 | change to “The Company’s primary business is the distribution of pharmaceuticals including western medicine, Chinese patented medicine, health care products and the provision of the related consulting services, for downstream distributors and the end users such as the chemists.” |
| 3 | not sure what the sentences mean |
| 4 | suggest to update the year from 2016 to more recent |
| 5 | change to “The Company established B2B e-commerce to better enhance sales and customer experiences. Now the Company can deliver fast search and inquiry, code scan, order placement, payment and settlement, at accelerated speed with efficient services for customers at anytime and from anywhere.” |
